New data suggests the risk of blood clots from Astra-Zeneca is 1 in 60,000.
Ontario is going to pause first doses of the Oxford Astra-Zeneca vaccine over concerns around blood clots.
Chief Medical Officer of Health Dr. David Williams made the announcement during a press briefing this afternoon. New data suggests the risk of blood clots from Astra-Zeneca is higher then previously thought at 1 in 60,000.
This is not expected to impact the vaccine rollout in Ontario thanks to increased supply from Pfizer and Moderna.
The Province is currently reviewing data for second doses and it is possible those who got the first shot of Astra-Zeneca could end up with a second dose from Pfizer or Moderna. According to recent data, the risk of blood clots from the second dose of Astra-Zeneca is much smaller.
Dr. Williams did say anyone who already received the first dose of Astra-Zeneca did the right thing and this decision was made out of an abundance of caution. He notes the increased supply of Moderna and Pfizer helped make this an easier decision.

TDMH Celebrates a Year of the RAFT
News Poll: Poppy Campaign Underway
SWPH Confirms Case of Influenza A
Public Input Needed for Woodstock Transit
Oxford OPP Briefs - Nov. 3rd, 2025
Interview with the Mayor - November 3rd, 2025
PJHL Recap - Oct 31st to Nov 2nd
Nominations Open for Runway of Stars
Ultimate Burger Battle Begins!
Dodgers Beat Blue Jays in World Series
Impaired Driver Caught in Tillsonburg
Norfolk OPP Investigating Break-and-Enter
PJHL Preview - Oct. 31st to Nov. 2nd
BBBS Volunteers Honoured in London
Poppy Campaign Begins Today
Daylight Saving Time Ends on Sunday
Local Police Offer Halloween Safety Tips
UPDATE: Missing Teen Located
Men's Health Talk Coming to Woodstock
WPS Search for Robbery Suspect
Comments
Add a comment